- Visibility 153 Views
- Downloads 113 Downloads
- Permissions
- DOI 10.18231/2394-5478.2018.0101
-
CrossMark
- Citation
Burden of ESBL with antibiogram in clinical isolates of E.coli and Klebsiella species from tertiary care hospital in central India
- Author Details:
-
Surender Kaur *
-
Abhijit Awari
Introduction and Objectives: The ESBLs producing organisms are reported worldwide in increasing numbers for which Clinical Laboratory Standard Institute (CLSI) recommends screening for ESBLs producing Escherichia coli and Klebsiella species by phenotypic methods. The study was undertaken to assess the burden of ESBL and comparison of Double Disc Synergy Test (DDST) and Phenotypic Confirmatory Test (PCT) with gold standard E-Test for ESBL detection in clinical isolates of tertiary care hospital, Bhopal.
Materials and Methods: 223 clinical isolates of E.coli and Klebsiellae species were included in the study and those showing zone size of < 22>
Result: Out of 223 isolates 124 were potential ESBL producers with preponderance of E.coli 58.3%. E-Test showed confirmed cases of ESBL 72/124(58%) which was much higher than by DDST 44/124 (35.5%) but close to PCT 70/124 (56.4%) among suspected clinical isolates. Overall ESBL burden out of 223 isolates was 32.28% which is quite alarming. ESBL producing strain showed maximum sensitivity to Colistin, polymixin-B & Imipenem nearing 100% whereas sensitivity ranging from 60 to 85% for beta lactamase inhibitor combinations. Non-ESBL producers were more sensitive to Amikacin, Fluoroquinolones, Nitrofurantoin, Cotrimoxazole with sensitivity ranging between 40 to 70%.
Conclusion: With rise in ESBL producing strains with multi drug resistance, screening with Ceftazidime should be done to detect probable ESBL producer. PCT can be used with confidence with comparable results with that of MIC tests in resource poor microbiology laboratories which will save human, technical and monitory resources in terms of its confirmation by molecular genotypic methods.
Keywords: DDST-Double Disc Synergy Test, PCT-Phenotypic confirmatory test, E-Test-Epsilometer Test.
References
- Calil R, Marba ST, Tresoldi AT. Reduction in colonization and nosocomial infection by multi resistant bacteria in neonatal unit after institution of educational measures and restriction in the use of cephalosporins. Infect Control Hospital Epidemiol. 2001;29:133-8.
- Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933-951.
- Jacoby GA, Medeiros AA. More extended-spectrum β- lactamases. Antimicrob Agents Chemother. 1991;35:1697-1704.
- Rodriguez-Bano J, Acala JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A. Community infections caused by extended- spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med. 2008;168:1897-1902.
- Collee JG, Miles RS, Watt B. Tests for identification of bacteria. In, Collee JG, Marmion BP, Fraser AG, Simmons A (eds).Mackie and McCartney Practical Medical Microbiology. 14th Edition. Delhi, Churchill Livingstone,2007;131-49. Surender Kaur et al. Burden of ESBL with antibiogram in clinical isolates of E.coli…. Indian Journal of Microbiology Research, October-December, 2018;5(4):497-503 503
- Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing twenty third informational supplemented. CLSI document M100- S23.Wayne, PA:CLSI;2013.
- Shukla I, Tiwari R, Agrawal M. Prevalence of extended spectrum β lactamase producing klebsiella pneumoniae in a tertiary care hospital. IJMM. 2004;22(2):87-91.
- AB BioMerieux, Solna, Sweden.
- Konean EW, Allen SD, Janda WM, Schreckenberger Pc, Winn WC. Antimicrobial susceptibility testing In Color atlas and textbook of diagnostic microbiology, 5 th Ed. Lippincott Williams and wikins Company 1997; pp 786, 798-801, 808, 831-832.
- Veena Krishnamurthy, Vijay Kumar G.S, Sudeepa Kumar M, Prashanth, Prakash R, Nagraj E R. Phenotypic and Genotypic methods for detection of extended spectrum β-lactamase in Escherichia coli and Klebsiella pneumoniae isolated from ventilator associated pneumoniae. Journal of Clinical and Diagnostic Research. 2013;7(9):1975-1978.
- Katsanis GP, Spargo J Ferraro, MJ Sutton L, Jacoby GA. Detection of Klebsiella pneumoniae and Escherchiae coli strains producing extended spectrum β –lactamases. J Clin Microbiol. 199;32(3):691-696.
- Maurine A. Leverstein-van Hall, Ad C. Fluit, Armand Paauw, Adrienne T. A. Box, Sylvain Brisse, and Jan Verhoef. Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 Automated Instruments for Detection of Extended-Spectrum Beta-Lactamases in Multiresistant Escherichia coli and Klebsiella spp. Journal of Clinical Microbiology. 2002:3703–3711.
- Anandkumar Harwalkar, Jagadeesh Sataraddi, Soham Gupta, Raksha Yoganand, Achut Raoa, Hiresave Srinivasa. The detection of ESBL-producing Escherichia coli in patients with symptomatic urinary tract infections using different diffusion methods in a rural setting. Journal of Infection and Public Health. 2013;6:108-114.
- Wattal C, Chugh TD, Sharma A, Overoi JK, Datta S. Microbiology Newsletter Sir Ganga Ram Hospital, 2005;10(1):1-8.
- Rajan S, Prabavathy J. Antibiotic Sensitivity and Phenotypic Detection of ESBL producing E.Coli Strains Causing Urinary Tract Infection In a Community Hospital, Chennai, Tamil Nadu, India. Webmed Central> Research articles 2012;11:1-15.
- Baby Padmini S, Appala Raju B, Mani KR. Detection of Enterobacteriaceae producing CTX-M Extended spectrum beta-lactamases from Tertiary care Hospital in south India. IJMM. 2008;26(2):163-6.
- C Rodrigues, P Joshi, SH Jani, M Alphonse, R Radhakrishnan, A Mehta. Detection of -Lactamases in nosocomial gram negative clinical isolates. IJMM. 2004;22(4):247-250.
- Gaurav Dalela. Prevalence of Extended Spectrum Beta Lactamase (ESBL) Producers among Gram Negative Bacilli from Various Clinical Isolates in a Tertiary Care Hospital at Jhalawar, Rajasthan India. Journal of clinical & Diagnostic Research. 2012;6(2):182-87.
- Nema Shashwati, Tripathi Kiran, A. G. Dhanvijay Study of extended spectrum β-lactamase producing Enterobacteriaceae and antibiotic coresistance in a tertiary care teaching hospital. Journal of Natural Science, Biology and Medicine. 2014;5(1):30-35.
- Avinash Laghawe, Neelam Jaitly, Vilas Thombare. The Simultaneous Detection of the ESBL and the AmpC b- Lactamases in Gram Negative Bacilli. Journal of Clinical and Diagnostic Research. 2012;6(4):660-663.
- Yazdi M, Nazemi A, Mirinargasi M, Jafarpour M, Sharifi SH. Genotypic versus Phenotypic methods to detect Extended-Spectrum Beta-Lactamases (ESBLs) in Uropathogenic Escherichia coli Scholars Research Library Annals of Biological Research. 2012;3(5):2454-
- Renuka Rampure, Ravindranath Gangane, Ajay Kumar Oli1, Kelmani Chandrakanth R. Prevalence of MDR- ESBL producing Klebsiella pneumoniae isolated from clinical Samples. J Microbiol Biotech Res. 2013;3(1):32-
- Martin G, Cormican, Steven A, Marshall, and Ronald N, Jones. Detection of ESBL producing strains by the E-test ESBL screen. J of Clin. Micro.1996:1880-1884.
- Jasmine Subashini and Krishnan Kannabiran. Screening and Identification of Extended Spectrum β-lactamase (ESBL) Pathogens in Urine Sample of UTI Patient’s. Trop Med Surg. 2013:1:3.
- Cormican MG, Marshall SA, Jones RN. Detection of Extended- strains by the E test ESBL screen. J ClinMicrobiol. 1996;34:1880-1884.
- P.L. Ho, K.H. Chow, K.Y. Yuen, W.S. Ng, P.Y. Chau Comparison of a novel, inhibitor – potentiated disc diffusion test with other methods for the detection of extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumonia. Journal of Antimicrobial Chemotherapy. 1998(42):49-54.
- Derek FJ, Brown, Jenny Andrews, Anna King and Alasdair P, MacGowan. Detection of Extended spectrum β-lactamase with E-test and double disc potentiation methods. Journal of Antimicrobial Chemotherapy. 2000;46(2):327–328.
- Anbumani Narayanaswamy and M. Mallika Prevalence and Susceptibility of extended spectrum beta-lactamases inurinary isolates of Escherichia coli in a Tertiary Care Hospital, Chennai-South India. Internet Journal of Medical Update. 2011;6(1):39-43.
- Enas Sh. Khater and Hammamouda W. Sherif. Rapid detection of extended spectrum β lactamase (ESBL) producing strain of Escherichia coli in urinary tract infections patients in Behna university hospital, Egypt. British microbiology Research Journal. 2014;4(4):443-
- Shields J, Maxwell AP. Acute pyelonephritis can have serious complications. Practitioner 2010;254:19, 21, 23- 4, 2.
How to Cite This Article
Vancouver
Kaur S, Awari A. Burden of ESBL with antibiogram in clinical isolates of E.coli and Klebsiella species from tertiary care hospital in central India [Internet]. Indian J Microbiol Res. 2018 [cited 2025 Oct 29];5(4):497-503. Available from: https://doi.org/10.18231/2394-5478.2018.0101
APA
Kaur, S., Awari, A. (2018). Burden of ESBL with antibiogram in clinical isolates of E.coli and Klebsiella species from tertiary care hospital in central India. Indian J Microbiol Res, 5(4), 497-503. https://doi.org/10.18231/2394-5478.2018.0101
MLA
Kaur, Surender, Awari, Abhijit. "Burden of ESBL with antibiogram in clinical isolates of E.coli and Klebsiella species from tertiary care hospital in central India." Indian J Microbiol Res, vol. 5, no. 4, 2018, pp. 497-503. https://doi.org/10.18231/2394-5478.2018.0101
Chicago
Kaur, S., Awari, A.. "Burden of ESBL with antibiogram in clinical isolates of E.coli and Klebsiella species from tertiary care hospital in central India." Indian J Microbiol Res 5, no. 4 (2018): 497-503. https://doi.org/10.18231/2394-5478.2018.0101